Millions of people around the world are still affected by the coronavirus pandemic, also known as COVID-19. As scientists scramble and increase efforts in developing and testing potential treatments and preventative measures, a new study suggests that CBD or cannabis may potentially become a cure for COVID-19.
Forbes reports some scientists are looking into the possibility of CBD becoming a COVID-19 cure or have some health benefits for those who are suffering from severe cases. The researchers then suggested that there are ways that cannabis-derived CBD could help severe coronavirus patients. One of which is the ability to reduce ACE2 expression and pro-inflammatory cytokine production that helps fight the inflammation of the lungs. Another is that it has the potential ability to be an antiviral treatment. However, not many studies have tested these theories.
But recently, the study from researchers at Georgia’s Augusta University suggests that CBD may benefit ARDS, also known as acute respiratory distress syndrome, which happens to be one of the severe symptoms of COVID-19. The researchers tested this theory on mice that were first given a dose of Poly(I:C) to artificially induce ARDS that has similar symptoms to COVID-19 patients. Once the mice were experiencing this syndrome, the researchers then gave them a dose of CBD. They noticed the impact CBD has in treating ARDS, which has resulted in a complete or semi-reversal of symptoms.
“Currently, other than supportive measures, there is no definitive cure for ARDS, illustrating the urgent need for creative and effective therapeutic modalities to treat this complex condition,” said the researchers. However, this study appears to add more weight to the possibility that CBD can be used as a possible cure for this dangerous symptom of COVID-19.
Meanwhile, according to the Russian representative for the World Health Organization Melita Vujnovic, it is possible that the virus may have been dormant all this time before it first broke out in Wuhan, China, in 2019. Chinese scientists, as well as the WHO has been looking into the origins of the virus by partnering to figure out where the virus came from.
Vujnovic explained that the virus was likely present in animals and somehow has passed onto humans. However, it proves difficult to specify when and where this all began.


Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation 



